ArticleJournal of clinical and translational hepatology2023

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.